SK Biopharmaceuticals. (326030.KQ) Q2 2025 Earnings

9MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
84.73
829.01
1,573.29
2,317.56

Details

Expected EPS
252.23195880000003
Actual EPS
235.93067741250002
Surprise EPS
-16.3
Surprise Percent
+6.46%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 235.93067741250002 per share for Q2 2025.

0 Comments

Share your thoughts